Basil Michelle L
SEC CIK 1699629 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HAE | HAEMONETICS CORP | EVP, GC | 40.4K | — | $5.27M | 30 | 2021-10-25 | 2026-05-15 |
Most active insiders at HAE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | KROLL MARK W | Dir | $98.8K | — |
| 2 | Chan Frank | EVP, COO | — | — |
| 3 | Maunsell Farris Maryanne | VP, CAO | — | — |
| 4 | Galvin Roy | EVP, Chief Commercial Off | — | — |
| 5 | Miller Laurie A. | SVP, Human Resources | — | — |
| 6 | Johnson Lloyd Emerson | Dir | — | — |
| 7 | Basil Michelle L | EVP, GC | — | — |
| 8 | Bryant Diane M | Dir | — | — |
| 9 | Simon, Christopher | Pres, CEO, Dir | — | — |
| 10 | Pomeroy Claire | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 17:37 | 2026-05-15 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $56.29 | -2,913 | 40.4K | -7% | -$164.0K | |
| 2026-05-19 17:37 | 2026-05-15 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | A - Grant | — | +28.4K | 68.8K | +70% | — | |
| DA | 2025-06-13 | 2025-05-16 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | A - Grant | — | +6,755 | 35.2K | +24% | — |
| 2025-06-03 | 2025-05-30 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | A - Grant | $0.00 | +15.6K | 49.7K | +46% | $0 | |
| 2025-06-03 | 2025-05-30 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $69.38 | -7,469 | 42.3K | -15% | -$518.2K | |
| D | 2025-05-20 | 2025-05-16 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | A - Grant | — | +5,689 | 34.2K | +20% | — |
| M | 2025-05-19 | 2025-05-15+ | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $70.10 | -2,779 | 28.5K | -9% | -$194.8K |
| M | 2024-05-29 | 2024-05-29 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale | $88.08 | -13.0K | 35.4K | -27% | -$1.14M |
| 2024-05-29 | 2024-05-28 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $95.73 | -11.8K | 44.2K | -21% | -$1.13M | |
| 2024-05-29 | 2024-05-28 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | A - Grant | $0.00 | +24.7K | 56.0K | +79% | $0 | |
| DM | 2024-05-21 | 2024-05-17+ | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale | $95.05 | -2,677 | 29.4K | -8% | -$254.4K |
| D | 2024-05-21 | 2024-05-17 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | A - Grant | — | +4,178 | 32.9K | +15% | — |
| D | 2024-05-21 | 2024-05-17 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $95.73 | -669 | 28.7K | -2% | -$64.0K |
| M | 2024-05-17 | 2024-05-15+ | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $95.62 | -862 | 31.4K | -3% | -$82.4K |
| 2024-05-17 | 2024-05-16 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale | $96.14 | -985 | 30.4K | -3% | -$94.7K | |
| 2023-10-24 | 2023-10-20 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $89.05 | -197 | 32.3K | -0.6% | -$17.5K | |
| 2023-05-19 | 2023-05-18 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $83.34 | -3,541 | 32.5K | -10% | -$295.1K | |
| D | 2023-05-17 | 2023-05-16 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $89.21 | -446 | 36.0K | -1% | -$39.8K |
| D | 2023-05-17 | 2023-05-15 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | A - Grant | — | +4,205 | 36.5K | +13% | — |
| 2023-05-16 | 2023-05-12 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | F - Tax | $88.16 | -204 | 32.3K | -0.6% | -$18.0K | |
| 2022-10-26 | 2022-10-24 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale | $80.39 | -180 | 32.5K | -0.6% | -$14.5K | |
| D | 2022-09-21 | 2022-09-19 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale+OE | $78.36 | -11.4K | 32.6K | -26% | -$897.1K |
| DM | 2022-09-21 | 2022-09-19 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | M - OptEx | $42.10 | +8,688 | 38.9K | +29% | +$365.7K |
| DM | 2022-09-19 | 2022-09-15 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | M - OptEx | $42.05 | +28.6K | 51.8K | +123% | +$1.20M |
| DM | 2022-09-19 | 2022-09-15 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale+OE | $77.89 | -33.8K | 35.4K | -49% | -$2.63M |
| 2022-06-15 | 2022-06-13 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale | $62.60 | -277 | 40.6K | -0.7% | -$17.3K | |
| 2022-05-23 | 2022-05-19 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale | $59.10 | -3,258 | 40.9K | -7% | -$192.5K | |
| D | 2022-05-18 | 2022-05-16 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale | $56.10 | -196 | 38.1K | -0.5% | -$11.0K |
| D | 2022-05-18 | 2022-05-16 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | A - Grant | — | +6,076 | 44.2K | +16% | — |
| 2021-10-27 | 2021-10-25 | HAE | HAEMONETICS CORP | Basil Michelle L | EVP, GC | S - Sale | $71.93 | -120 | 38.3K | -0.3% | -$8,632 |
Purchase Sale Sale after option exercise All abbreviations